Advisors Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.16M | Buy |
|
|||||
|
2025
Q1 | $4.34M | Buy |
|
|||||
|
2024
Q4 | $3.47M | Sell |
|
|||||
|
2024
Q3 | $3.53M | Buy |
|
|||||
|
2024
Q2 | $2.57M | Sell |
|
|||||
|
2024
Q1 | $3.59M | Buy |
|
|||||
|
2023
Q4 | $3.37M | Sell |
|
|||||
|
2023
Q3 | $3.73M | Sell |
|
|||||
|
2023
Q2 | $4.33M | Buy |
|
|||||
|
2023
Q1 | $5.28M | Buy |
|
|||||
|
2022
Q4 | $5.91M | Buy |
|
|||||
|
2022
Q3 | $3.22M | Buy |
|
|||||
|
2022
Q2 | $1.74M | Buy |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $298K | Buy |
|